Current management of hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy is a familial cardiac disorder with heterogeneous expression and a diversity of morphological, functional and clinical features. Some individuals with hypertrophic cardiomyopathy may be asymptomatic while others are disabled by symptoms of angina and breathlessness. This article summarizes the genetics, pathophysiology and present management of this important condition.
London Chest Hospital, London E2 9JX.
P
P
Golledge
C J
CJ
Knight
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000209:etiology; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D009154:Mutation / Q000235:genetics; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents